The future of point-of-care diagnostics
Fluxergy’s platform is uniquely positioned to transform in-house testing with scalable and multimodal technology, certified for diagnostic use.
Featured assays
HVRe Influenza / RSV / SARS-CoV-2 Respiratory Panel
COVID-19 PCR Test Kit
Human Assay Pipeline
We are excited to continue development of impactful human panels. Fluxergy is ISO:13485 compliant and is currently in process of 510K submissions for molecular and cytometry based assays. Our current product line is highlighted by s a fully room temperature stable and CLIA-waivable, CE-marked human respiratory panel that detects influenza A/B, RSV, and COVID-19.
Available
In Development
Potential
Multiple test types, one analyzer
Our platform can read molecular, immunochemistry, chemistry, PCR and cytometry assays, giving you the ability to run a variety of diagnostic tests in-house.
How wecan help
Test multiple parameters
The Fluxergy platform is a multimodal system that allows testing for a variety of targets.
Get fast, accurate, actionable results
Ideal for point-of-care use, the Fluxergy Analyzer can produce results in 15 to 60 minutes from test card insertion.
Use low-cost consumables
Fluxergy uses a highly integrated and manufacturable consumable for Sample-to-Answer testing.
Simplify your workflow
We offer easy-to-use test kit workflows and convenient software to securely manage, store, and read data.
Resource Center
Explore Fluxergy's information hub with webinars, product materials, how-to-videos, and more.
Dr. Lucjan Witzkowski, DVM, PhD
Warsaw University of Life Sciences
.svg)
.svg)